World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
29656
World Ranking
14044
National Ranking
50

Do-Hyun Nam publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Do-Hyun Nam sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 498 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Do-Hyun Nam D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Do-Hyun Nam sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Do-Hyun Nam is affiliated with the Samsung Medical Center in South Korea. Their research focuses primarily on medicine, with significant contributions in biochemistry, genetics, and molecular biology. Within these fields, notable subfields include molecular biology, genetics, oncology, cancer research, and pulmonary and respiratory medicine.

The scientist's main research topics include glioma diagnosis and treatment, cancer cells and metastasis, cancer genomics and diagnostics, meningioma and schwannoma management, 3D printing in biomedical research, lung cancer treatments and mutations, and head and neck surgical oncology.

Do-Hyun Nam has published extensively in several scientific journals. Frequent venues of publication include Nature Communications, Cancer Research, Cancers, Neuro-Oncology, and Research Square. These journals reflect a focus on cancer biology and translational medical research.

Selected recent papers that illustrate the range of their work are:

  • Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy, 2020, Nature Communications
  • ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages, 2020, Nature Communications
  • Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma, 2020, Genome Biology
  • Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities, 2020, Nature Communications
  • Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling, 2023, Cancer Cell

Frequent collaborators include K. Jason, Hee Jin Cho, Doo-Sik Kong, Ho Jun Seol, and Jung-Il Lee. The collaborative relationships suggest ongoing interdisciplinary work in oncology and molecular biology.

Best Publications

  • Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

    Qianghu Wang;Baoli Hu;Xin Hu;Xin Hu;Hoon Kim

  • Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    Roger Stupp;Roger Stupp;Monika E Hegi;Thierry Gorlia;Sara C Erridge

  • SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma

    Myung Jin Son;Kevin D Woolard;Do Hyun Nam;Jeongwu Lee

  • Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells

    Eunhee Kim;Misuk Kim;Dong Hun Woo;Yongjae Shin

  • Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.

    Hyon Bin Na;Jung Hee Lee;Kwangjin An;Yong Il Park

  • Clonal evolution of glioblastoma under therapy.

    Jiguang Wang;Emanuela Cazzato;Erik Ladewig;Veronique Frattini

  • CGCG clinical practice guidelines for the management of adult diffuse gliomas

    Tao Jiang;Do-Hyun Nam;Zvi Ram;Wai-Sang Poon

  • Longitudinal molecular trajectories of diffuse glioma in adults

    Floris P. Barthel;Kevin C. Johnson;Frederick S. Varn;Anzhela D. Moskalik

  • Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

    Kyeung Min Joo;Shi Yean Kim;Xun Jin;Sang Yong Song

  • Spatiotemporal Evolution of the Primary Glioblastoma Genome

    Jinkuk Kim;Jinkuk Kim;In Hee Lee;Hee Jin Cho;Hee Jin Cho;Chul Kee Park

  • Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.

    Marat S. Pavlyukov;Hai Yu;Hai Yu;Soniya Bastola;Mutsuko Minata

  • Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells

    Kyu-Tae Kim;Kyu-Tae Kim;Hye Won Lee;Hae-Ock Lee;Hae-Ock Lee;Sang Cheol Kim

  • WNT signaling in glioblastoma and therapeutic opportunities.

    Yeri Lee;Jin Ku Lee;Sun Hee Ahn;Jeongwu Lee

  • Spatiotemporal Genomic Architecture Informs Precision Oncology in Glioblastoma

    Jin Ku Lee;Jiguang Wang;Jiguang Wang;Jason K. Sa;Jason K. Sa;Erik Ladewig

  • Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.

    Huimin Hu;Quanhua Mu;Zhaoshi Bao;Yiyun Chen

  • Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

    L. Burt Nabors;Karen L. Fink;Tom Mikkelsen;Danica Grujicic

  • Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma

    Ana C. Decarvalho;Hoon Kim;Laila M. Poisson;Mary E. Winn

  • Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.

    Su Jin Lee;Jung Il Lee;Do Hyun Nam;Young Chan Ahn

  • Erratum: Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment (Cancer Cell (2017) 32(1) (42–56.e6)(S1535610817302532)(10.1016/j.ccell.2017.06.003))

    Qianghu Wang;Baoli Hu;Xin Hu;Hoon Kim

  • Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma.

    Kyu-Tae Kim;Hye Won Lee;Hae-Ock Lee;Hae-Ock Lee;Hye Jin Song

Frequent Co-Authors

Woong-Yang Park
Woong-Yang Park Samsung Medical Center
Jeongwu Lee
Jeongwu Lee Case Western Reserve University
Hyunggee Kim
Hyunggee Kim Korea University
Jeeyun Lee
Jeeyun Lee Sungkyunkwan University
Antonio Iavarone
Antonio Iavarone Columbia University Medical Center
Ichiro Nakano
Ichiro Nakano University of Alabama at Birmingham
Cheolju Lee
Cheolju Lee Korea Institute of Science and Technology
Keunchil Park
Keunchil Park The University of Texas MD Anderson Cancer Center
Won Ki Kang
Won Ki Kang Samsung Medical Center
Raul Rabadan
Raul Rabadan Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medical school, online programs offer flexible and affordable alternatives. Aspiring nurses, for example, may want to consider what is the fastest way to become an lpn, as fast-track LPN programs can quickly open doors to patient care roles.

Students passionate about mental health can explore psych nurse practitioner programs. These specialized MSN degrees often have accelerated online options and can lead to rewarding roles supporting those with psychiatric and behavioral health needs.

If you’re interested in the business or administrative side of healthcare, you might look into the cheapest online health science degree programs. These programs allow you to build a strong foundation in healthcare management while keeping tuition costs manageable.

For advancement into leadership, a master’s degree can have a big impact. If cost is a concern, investigate mha degree cost to compare the most affordable master’s in healthcare administration options. This pathway can prepare you for higher-level roles in hospitals, clinics, and other healthcare organizations.

Best Scientists Citing Do-Hyun Nam

Trending Scientists

Recently Published Articles